9 Meters Biopharm

$1.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
+$0.01 (+0.79%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell NMTR and other stocks, options, and ETFs commission-free!

About NMTR

9 Meters Biopharma, Inc. Common Stock, also called 9 Meters Biopharm, is a clinical-stage biopharmaceutical company. It focuses on developing novel medicines for autoimmune inflammatory disease. The company is founded by Jay P. Madan and Kendyle Woodard in 2012 and is headquartered in Raleigh, NC. The listed name for NMTR is 9 Meters Biopharma, Inc. Common Stock.

CEO
John Temperato
Employees
8
Headquarters
Raleigh, North Carolina
Founded
2012
Market Cap
258.32M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
24.54M
High Today
$1.29
Low Today
$1.22
Open Price
$1.28
Volume
5.40M
52 Week High
$1.77
52 Week Low
$0.3701

Collections

NMTR Earnings

-$0.57
-$0.38
-$0.19
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 18, Pre-Market

You May Also Like

SPXU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure